Clinical trial
Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial)
NCT00473876 · University of Dundee, Other · Completed
Key facts
| NCT number | NCT00473876 |
|---|---|
| Title | Metformin in Insulin Resistant Left Ventricular (LV) Dysfunction (TAYSIDE Trial) |
| Official title | Metformin in Insulin Resistant LV Dysfunction, a Double-blind, Placebo-controlled Trial (TAYSIDE Trial) |
| Acronym | TAYSIDE |
| Lead sponsor | University of Dundee, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure, Insulin Resistance |
| Intervention type | Drug |
| Interventions | Metformin, Matched Placebo (Capsules) |
| Enrollment | 62 |
| Start date | Aug 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | May 16, 2007 |
| Last update posted | Jun 6, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: